Deep-Tech Oncology

Plasma-Engineered Biomaterials for Precision Oncology

We combine cold atmospheric plasma physics with bio-interactive hydrogels to engineer localized oncology matrices, transforming targeted drug delivery and microenvironment modulation.

Our Unique Approach

Targeting the Tumor Microenvironment

PlasmOnCo's biomaterials are designed for precise interaction with the cellular microenvironment, enabling unprecedented control over biological responses at the site of disease.

Our Commitment

Modulating Biological Responses at Cell Level

From fundamental physics to translational oncology, our therapeutic platforms bridge laboratory discovery with human impact, accelerating the development of advanced cancer therapeutics.

Social Impact

Transforming Cancer Care

Our solution has the potential to deliver more effective cancer care while reducing the burden on patients and healthcare systems. Fewer recurrences and secondary surgeries could mean lower healthcare costs and improved long-term outcomes. By enabling more conservative treatments, we aim to increase survival chances and to help patients preserve function, quality of life, and hope beyond cancer.

Localized Action

Personalized Treatment

Selective Effect

Enhance therapeutic concentration directly at the tumor site, maximizing efficacy and improving local tumor control.

Versatile platform adaptable to each patient's requirements, precisely conforming to the morphology of the resected cavity or the affected site. Its flexibility allows patient-specific treatment across multiple cancer types.

Selective elimination of cancer cells while preserving healthy tissues, minimizing local and systemic toxicity through targeted therapeutic action, while offering potential synergies with existing cancer treatments.

Partner with PlasmOnCo

We invite researchers, clinicians, investors & pharmaceutical partners to explore our platform and collaborate on the next generation of oncology solutions.